Comparison of the effects of D-003 and policosanol on lipid profile and endothelial cells in normocholesterolemic rabbits

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 3, 2001, Pages 209-220

  Mendoza, Sarahí ^a   Gámez, Rafael ^a   Noa, Miriam ^a   Más, Rosa ^a   Castaño, Gladys ^b   Mesa, Rosario ^a   Mesa, Meilis ^b   De Armas, Michel ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^b Medical Surgical Research Center   (Cuba)

Author keywords

Cholesterol lowering drugs; D 003; Endothelial cells; Policosanol

Indexed keywords

CHOLESTEROL; CITRIC ACID; D 003; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLICOSANOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

EID: 0035057937     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80032-1     Document Type: Article

References (49)

1. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease
2. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
3. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
6. Long-term intervention with pravastatin in ischemic disease (LIPID) study
7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
8. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
9. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
10. Cholesterol-lowering effects of policosanol in rabbits
11. Effects of policosanol chronically administered in male monkeys (Macaca arctoides)
12. Effect of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolemia and tolerability to treatment
13. Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia
14. One-year study of the efficacy and safety of policosanol (5 mg twice daily) in the treatment of type II hypercholesterolemia
15. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipo proteinaemia
16. Effects of policosanol on hypercholesterolemic patients with disturbances in serum biochemical indicators of hepatic function
17. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
18. Treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus (NIDDM) with policosanol
19. Effect of policosanol on patients with non-insulin-dependent diabetes mellitus (NIDDM) and hypercholesterolemia
20. Policosanol inhibits cholesterol biosynthesis and enhances LDL processing in cultured human fibroblasts
21. Effects of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats
22. Cholesterol-lowering effects of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet
23. Effects of policosanol on platelet aggregation in rats
24. Effect of policosanol on cerebral ischemia in Mongolian gerbils: Role of prostacyclin and thromboxane A2
25. Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers
26. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers
27. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation
28. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro
29. Effect of policosanol on circulating endothelial cells in experimental models in Sprague-Dawley rats and rabbits
30. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients
31. Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits
32. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D-003, a mixture of very long chain saturated fatty acids
33. Antithrombotic effects of D003
34. Interaction of policosanol-warfarin on bleeding time and thrombosis in rats
35. Circulating endothelial cells in acute myocardial infarction and angina pectoris
36. Separation of serum high-density lipoprotein for cholesterol determination: Ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride
37. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
38. Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats
39. Statistical considerations for performing multiple tests in a single experiment. 5. Comparing two therapies with respect to several endpoints
40. Metabolism of octacosanol in liver and muscle of rat
41. Policosanol
42. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle
43. Endothelial function. General considerations
44. Biology of the endothelium
45. Prevention of exercise-induced endothelemia by isradipine in men with angina pectoris
46. Interference of levamisole with Forssman shock
47. Effect of CNIC-4 (lobenzarit) on circulating endothelial cells of rats. Advances in lipoprotein and atherosclerosis research, diagnostics and treatment